Loading
Nirvana Life Sciences In. Stock: price and insider trades · Canada
Nirvana Life Sciences In.: what insiders have been doing
This page follows insider dealings at Nirvana Life Sciences In. as filed with SEDI, a company from the Health Care sector. The last twelve months, up to 23 October 2026, brought 4 filings signed by 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 2,471 companies) published 12 filings over the same period, against 4 filings here. The full history, which starts in 2023, counts 4 purchases against no sales.
There has been no open-market purchase by an insider of Nirvana Life Sciences In. for at least a year. Filings reach the SEDI feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
20
Thresholds
n/a
Buy Volume
€89,794
4 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleSheldon Inwentash3 buys
Jakson Samuel Inwentash1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended April 2025 · cache
CA$0.05
Analyst consensus
Income statement
EBITDA-CA$365.9k
Net income-CA$365.9k0.0% margin
Valuation
PER (trailing)5.0x
Beta-0.93
Balance sheet & cash
Total debtCA$98.5k
Free Cash Flow-CA$69.5k
Profitability & ownership
ROA-1018.4%
% insiders24.0%
% institutions0.0%
Last declaration on 9 September 2026
Declarations20 total
WarrantsTSXSEDI:4775214
Common SharesTSXSEDI:4775213
WarrantsTSXSEDI:4775212
Common SharesTSXSEDI:4775211
1,416,468 shares@ CA$0.0558.3% of flowCommon SharesTSXSEDI:4591330
Canonical exit: 2 Oct 2025 (T+90)
439,567 shares@ CA$0.05100.0% of flowCommon SharesTSXSEDI:4591320
Canonical exit: 2 Oct 2025 (T+90)
439,567 shares@ CA$0.0518.1% of flowCommon SharesTSXSEDI:4591318
Canonical exit: 2 Oct 2025 (T+90)
574,322 shares@ CA$0.0523.6% of flowCommon SharesTSXSEDI:4591316
Canonical exit: 2 Oct 2025 (T+90)
Common SharesTSXSEDI:4591319
Common SharesTSXSEDI:4591317
1,150,000 shares@ CA$0.0530.4% of flowCommon SharesTSXSEDI:4551972
2,627,559 shares@ CA$0.0569.6% of flowCommon SharesTSXSEDI:4551973
1,500,000 sharesCommon SharesTSXSEDI:4533069
3,575,000 sharesCommon SharesTSXSEDI:4533075
500,000 sharesCommon SharesTSXSEDI:4533088
150,000 sharesCommon SharesTSXSEDI:4533071
357,500 sharesCommon SharesTSXSEDI:4533076
50,000 sharesCommon SharesTSXSEDI:4533089
2,000,000 shares@ CA$0.0536.8% of flowCommon SharesTSXSEDI:4130680
Common SharesTSXSEDI:4130030
20 of 20 declarations
About Nirvana Life Sciences In.
Nirvana Life Sciences In. is a company listed on the XTSE, specializing in the life sciences sector. It focuses on developing innovative solutions to enhance health and well-being.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
